Results 61 to 70 of about 402 (126)
Soluble ST2 – a new biomarker in heart failure
Cardiovascular Medicine, 2019 This article summarises insights and discussion points from the first meeting of the Swiss working group on cardiovascular biomarkers.
Patric Biaggi +7 more
openaire +1 more source
Soluble ST2 in Heart Failure With Preserved Ejection Fraction
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017 BackgroundSoluble ST2 is a biomarker that is elevated in certain systemic inflammatory diseases. Comorbidity‐driven microvascular inflammation is postulated to play a key role in heart failure with preserved ejection fraction (HFpEF) pathophysiology, but
Omar F. AbouEzzeddine +9 more
doaj +1 more source
Molecular Plant Pathology, Volume 27, Issue 7, July 2026.Efforts to mimic the pepper PVY‐resistant pvr21 allele in potato using Cas12a‐mediated single‐stranded oligodeoxynucleotide (ssODN) editing of eIF4E1, while highlighting key technical limitations, shed light on a dominant‐negative PVY resistance mechanism.
Alessandra Lucioli +5 more
wiley +1 more source
A Novel Cardiac Bio-Marker: ST2: A Review
Molecules, 2013 Cardiovascular diseases (CVD) are the major cause of death worldwide. The identification of markers able to detect the early stages of such diseases and/or their progression is fundamental in order to adopt the best actions in order to reduce the ...
Marco Matteo Ciccone +7 more
doaj +1 more source
Programmed Cell Death in Chronic Rhinosinusitis
Clinical and Translational Allergy, Volume 16, Issue 6, June 2026.ABSTRACT Chronic rhinosinusitis (CRS) is a prevalent upper respiratory condition characterized by a multifaceted etiology involving various cellular and molecular processes. In recent years, researchers have increasingly recognized the significance of different forms of programmed cell death (PCD), such as apoptosis and pyroptosis, in the pathological ...
Xingchen Liu +5 more
wiley +1 more source
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution [PDF]
BMC Gastroenterology, 2016 The ST2/IL-33 pathway has been related to ulcerative colitis (UC), and soluble ST2 (sST2), to disease severity. We tested the potential usefulness of sST2 as a predictive marker of treatment response and patients' outcome.Twenty-six patients with active UC were prospectively recruited and grouped according to an endoscopic score and therapy response ...
Díaz Jiménez, David +9 more
openaire +2 more sources
European Journal of Immunology, Volume 56, Issue 6, June 2026.Using cyclic multiplex microscopy in an IL‐33‐driven type 2 inflammation model, we validated a spatial workflow mapping rare lung ILCs. High‐dimensional analysis revealed a conserved peri‐lymphatic niche at early time points of inflammation where ILC2s and myeloid cells co‐localize with LYVE1+ vessels, highlighting a structured immunological ...
Sandy Kroh +10 more
wiley +1 more source
Vascular Health and Risk Management, 2017 Dike B Ojji,1,2 Sandrine Lecour,2 Olusoji M Adeyemi,3 Karen Sliwa2,4 1Cardiology Unit, Department of Medicine, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria; 2Department of Medicine, Faculty of Health Sciences, Hatter Institute for ...
Ojji DB, Lecour S, Adeyemi OM, Sliwa K
doaj
Zhongguo aizheng zazhi, 2020 Background and purpose: Soluble suppression of tumorigenicity2 (sST2) is a biomarker of myocardial hypertrophy and myocardial fibrosis. This study aimed to investigate the clinical value of sST2 in patients with soft tissue sarcomas.
LIN Jinyi +5 more
doaj